Trial Profile
A 4-week, Open Label, Multi-center, Prospective, Single-arm, Non-interventional Phase IV Study to Evaluate the Efficacy of Targin for the Treatment of Korean Patients With Cancer Pain Under Conditions of Daily Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms PROBE
- Sponsors Mundipharma International
- 07 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 05 Dec 2012 New trial record